Autologous Platelet-Rich Plasma (PRP)

BIOLOGICAL13 trials

Sponsors

Institut de Terapia Regenerativa Tissular, University of Miami, Jennifer R. Arthurs, Uludag University, Pamukkale University

Conditions

Conditioned SerumEpisiotomyErectile Dysfunction With Diabetes MellitusGenital Diseases, MaleGenitourinary Syndrome of Menopause (GSM)Knee Arthritis OsteoarthritisMacular HolesMuscle Injuries

Phase 1

A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus

CompletedNCT04967170

Jennifer R. ArthursVulvar Lichen Sclerosus

Start: 2022-01-19End: 2025-12-12Updated: 2026-07-22

Combining Shockwave Therapy and Platelet Rich Plasma to Treat Erectile Dysfunction in Diabetic Men (COCKTAIL-DM)

TerminatedNCT05525572

University of MiamiErectile Dysfunction With Diabetes Mellitus

Start: 2024-02-12End: 2024-08-02Updated: 2025-02-28

Phase 2

PRP for Treatment of Peyronie's Disease

CompletedNCT04512287

University of MiamiGenital Diseases, Male, Peyronie Disease, Sexual Dysfunction Male +1

Start: 2021-03-29End: 2025-08-11Updated: 2026-08-03

Phase 3

Efficacy of Platelet Rich Plasma for Treatment of Muscle Rupture With Haematoma

CompletedNCT01440725

Institut de Terapia Regenerativa TissularMuscle Injuries

Start: 2009-10-31End: 2012-12-31Updated: 2013-01-10

Phase 4

PRP vs PRP+Betamethasone vs Betamethasone Injection for Upper Trapezius Myofascial Pain

RecruitingNCT07547605

University of KyreniaMyofascial Pain Dysfunction Syndrome, Trigger Point in Trapezius Muscle, Trigger Points, Myofascial

Start: 2026-05-15End: 2027-01-01Target: 150Updated: 2026-06-16

Injection Therapies for Partial Rotator Cuff Tears

CompletedNCT07871695

Ankara Ataturk Sanatorium Training and Research HospitalPartial-Thickness Rotator Cuff Tear

Start: 2024-10-15End: 2026-01-08Updated: 2026-10-13

Unknown Phase

Platelet-Rich Plasma for Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Prospective Randomized Controlled Study

CompletedNCT07330713

Uludag UniversityNonarteritic Anterior Ischemic Optic Neuropathy

Start: 2022-01-01End: 2024-05-31Updated: 2026-01-09

Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)

RecruitingNCT07473232

Pamukkale UniversityConditioned Serum, Knee Arthritis Osteoarthritis, Platelet Rich Plasma Injection

Start: 2026-04-01End: 2026-10-30Target: 60Updated: 2026-08-20

Full-Thickness Macular Hole Surgery: A Comparison of Ten Techniques

RecruitingNCT07606404

Kazakh Eye Research InstituteMacular Holes

Start: 2026-05-25End: 2028-05-27Target: 120Updated: 2026-06-02

Platelet-Rich Plasma Versus Standard Care for Episiotomy Wound Healing in Postpartum Women

Not yet recruitingNCT07669285

Saint Andrew Hospital ConstantaEpisiotomy, Obstetric, Platelet Rich Plasma (PRP) +1

Start: 2026-06-21End: 2028-12-30Target: 200Updated: 2026-06-30

Intra-Ovarian PRP Compared With Gonadotropin for Ovarian Response in Letrozole-Resistant PCOS

CompletedNCT07777640

Bangladesh Medical UniversityPolycystic Ovary Syndrome (PCOS)

Start: 2025-06-01End: 2026-05-28Updated: 2026-08-20

CO₂ Laser With or Without Platelet-Rich Plasma for Genitourinary Syndrome of Menopause

CompletedNCT07863739

National and Kapodistrian University of AthensGenitourinary Syndrome of Menopause (GSM)

Start: 2023-06-01End: 2025-04-01Updated: 2026-10-08

Vaginal Platelet-Rich Plasma and Vaginal Histology in Genitourinary Syndrome of Menopause

CompletedNCT07905820

National and Kapodistrian University of AthensGenitourinary Syndrome of Menopause (GSM)

Start: 2023-04-01End: 2026-07-31Updated: 2026-10-29

Related Papers

(112) Efficacy and Safety of Platelet-Rich Plasma Injections for Peyronie’s Disease: A Randomized Double-Blind Placebo-Controlled Cross-Over Study

The Journal of Sexual Medicine2024-02-01

(162) Safety and Feasibility of Platelet-Rich Plasma Injections for Peyronie’s Disease: A Randomized Double-blind Placebo-controlled Cross-over Study

The Journal of Sexual Medicine2023-05-01

MP36-10 SAFETY AND FEASIBILITY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE DISEASE: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER STUDY

The Journal of Urology2023-03-23